Managing the risks of the Covid-19 pandemic remains a challenge. While EU vaccination rates have reached three quarters of the population, new SARS-CoV-2 variants keep emerging in the EU. Although these variants appear to be generally less severe, they still pose challenges to health systems. The implementation of a globally effective vaccine strategy remains key to enhancing Europe's resilience. If measures are successful, it is expected that SARS-CoV-19 – while still present – will enter a stage of seasonality, characterised by higher case numbers in the winter months, similarly to the flu. To achieve this, rethinking present surveillance and monitoring schemes, ensuring the distribution of vaccines worldwide and implementing an action plan against disinformation and misinformation could be crucial.

EPRS STOA podcast - Responding better to future pandemics

The arrival of the Covid-19 vaccines marks a turning point in the fight against the coronavirus pandemic. According to estimates, coverage of at least 60 % to 75 % is needed to establish population immunity through vaccination. But, as regards Covid-19 vaccination, surveys suggest that Europeans are among the most sceptical in the world.

EPRS policy podcast - Covid-19 vaccination campaigns: The public dimension

As COVID-19 has proved once again, diseases do not recognise borders… So, with labs around the world on the race to find a vaccine, it is time to ask ourselves the question: What can the EU do to help? Is there a European added value concerning vaccination?

EPRS policy podcast - Towards a joint European approach on vaccination

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session -  The state of play of the EU's COVID-19 Vaccination Strategy

Dubji dwar it-tilqim u tnaqqis fir-rati tat-tlaqqim fl-Ewropa (dibattitu)

Vaccine hesitancy and drop in vaccination rates in Europe (debate)

Sostenn kontinwu u ikbar għall-vaċċinazzjonijiet f'pajjiżi li qegħdin jiżviluppaw (dikjarazzjoni bil-miktub)

Poursuite et renforcement du soutien aux campagnes de vaccination dans les pays en développement (written declaration)

It-tilqima kontra l-bluetongue (dibattitu)

Vaccination against bluetongue (debate)

EP plenary session.- EU global strategy on COVID-19 vaccinations

Coronavirus - Vaccinations of healthcare professionals

EP Plenary session - Preparation of an EU Strategy on COVID-19 vaccination, including its external dimension

Vaccination campaign

EP Plenary sessionTransparency of the Purchase as well as the Access to COVID-19 vaccinations

EP Plenary session - Transparency of the Purchase as well as the Access to COVID-19 vaccinations

Cattle vaccination campaign

Plenary session.- Motions for resolutions - Vaccine hesitancy and drop in vaccination rates in Europe

Vaccination campaign of children

Vaccination booklet

ENVI committee meeting. Vote on Vaccine hesitancy and drop in vaccination rates in Europe

Health Related Matters

Ahead of the 17-18 February European Union-African Union summit in Brussels, MEPs review the EU’s relations with Africa on Tuesday afternoon. The discussion focuses on the common challenges facing both continents, including the recovery from the COVID-19 pandemic, boosting vaccination and stimulating investments. Closing statement by Josep BORRELL, Vice-President of the Commission/High Representative of the Union for Foreign Affairs and Security Policy.

EU-Africa relations: closing statement by Josep BORRELL, Vice-President of the Commission/High Representative of the Union for Foreign Affairs and Security Policy

This stockshot shows illustration footage of the first arrival of vaccines in Côte d'Ivoire, and the first people being vaccinated against coronavirus, on 1 March 2021. The stockshot ends with a series of statements by representatives of the Côte d’Ivoire, the EU, the UN and UNICEF, recorded on 26 February 2021.

Infoclip: Coronavirus - First vaccinations in Côte d’Ivoire

During the plenary session of the European Parliament in Brussels (8-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy. Extracts.

The state of play of the EU's COVID-19 Vaccination Strategy: extracts from the debate

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy. Opening statements by Ana Paula ZACARIAS, Portuguese Secretary of State for European Affairs and Presidence in office of the Council of the EU, and by Ursula von der LEYEN, President of the European Commission. This transcription speech is the result of an automatic process. Check against delivery.

The state of play of the EU's COVID-19 vaccination strategy: opening statements by Ana Paula ZACARIAS, Portuguese Secretary of State for European Affairs, and Ursula von der LEYEN, President of the European Commission

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy.

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 4)

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 1)

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy. Arrival of Ursula von der LEYEN, President of the European Commission and ambiance shots prior to the plenary session

The state of play of the EU's COVID-19 vaccination strategy: arrival of Ursula von der LEYEN, President of the European Commission and ambiance shots prior to the plenary session

During the plenary session of the European Parliament in Brussels (08-11 February 2021), MEPs debate the state of play of the EU's COVID-19 Vaccination Strategy. Closing statements by Ana Paula ZACARIAS, Portuguese Secretary of State for European Affairs and Presidence in office of the Council of the EU, and Stella KYRIAKIDES, European Commissioner for Health and Food Safety

The state of play of the EU's COVID-19 vaccination strategy: closing statements by Stella KYRIAKIDES, European Commissioner for Health and Food Safety and by Ana Paula ZACARIAS, Portuguese Secretary of State for European Affairs

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 2)

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 3)

The state of play of the EU's COVID-19 vaccination strategy: MEPs debate (part 4 continuation)

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations.Opening statements by Ana Paula ZACARIAS, Portugese Council presidency and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety. This transcription speech is the result of an automatic process. Check against delivery.

EU global strategy on COVID-19 vaccinations: Opening statements by Ana Paula ZACARIAS, Council presidency and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations.Closing statements by Ana Paula ZACARIAS, Portugese Council presidency and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

EU global strategy on COVID-19 vaccinations: Closing statements by Ana Paula ZACARIAS, Council presidency and by Stella KYRIAKIDES, European Commissioner for Health and Food Safety

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs expressed broad support for the common EU approach to fighting the pandemic and called for complete transparency regarding contracts and deployment of COVID-19 vaccines. Statements by Ana Paula ZACARIAS, Council Presidency, Stella KYRIAKIDES, European Commissioner for Health and Food Safety, Esther de LANGE (EPP, NL), Iratxe GARCÍA PÉREZ (S&D, ES), Philippe LAMBERTS (Greens/EFA, BE), Marc BOTENGA (The Left, BE), Peter LIESE (EPP, DE), Pascal CANFIN (RE, FR).

EU global strategy on COVID-19 vaccinations: extracts from the debate

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs debate 3/3

EU global strategy on COVID-19 vaccinations: MEPs debate 3/3

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs debate 1/3

EU global strategy on COVID-19 vaccinations: MEPs debate 1/3

During the plenary session of the European Parliament in Brussels (18-21 January 2021), MEPs debate on the EU global strategy on COVID-19 vaccinations. MEPs debate 2/3

EU global strategy on COVID-19 vaccinations: MEPs debate 2/3

Vaccinations against COVID-19 started across the EU on December 27 2020. The European Commission has given conditional marketing authorisation for two COVID-19 vaccines, one developed by BioNTech and Pfizer and one by Moderna Biotech Spain, S.L. after the European Medicines Agency (EMA) concluded its assessments of these vaccines. This infoclip shows the vaccination campaign for medical staff in an hospital of Strasbourg (France): preparation of vaccine doses and vaccination sessions.

528 riżultati

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy

EP plenary session - The state of play of the EU's COVID-19 Vaccination Strategy